New neplanocin analogues. V. A potent adenosylhomocysteine hydrolase inhibitor lacking antiviral activity. Synthesis and antiviral activity of 6′-carboxylic acid derivatives of neplanocin A

Nucleosides and Nucleotides

Volumn 15, Issue 6, 1996, Pages 1157-1167

  Obara, Takumi ^a   Shuto, Satoshi ^b   Saito, Yasuyoshi ^a   Toriya, Minoru ^a   Ogawa, Kiyoshi ^a   Yaginuma, Satoshi ^a   Shigeta, Shiro ^c   Matsuda, Akira ^b  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ORYCTOLAGUS CUNICULUS; RNA VIRUSES;

9 (4 CARBAMOYL 2,3 DIHYDROXY 4 CYCLOPENTENYL)ADENINE; ADENOSYLHOMOCYSTEINASE; NEPLANOCIN A; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; ERYTHROCYTE; RABBIT; RNA VIRUS;

EID: 0030004625     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319608007384     Document Type: Article

References (20)

1. This paper constitutes part 146 of Nucleosides and Nucleotides. Part 145. Shuto, S.; Haramuishi, K.; Matsuda, A. Tetrahedron Lett. Submitted.
2. Ueland, P.M. Pharmacol. Rev. 1982, 34, 223-253.
3. De Clercq, E. Biochem. Pharmacol. 1987, 36, 2567-2575.
4. Wolfe, M. S.; Borchardt, R. T. J. Med. Chem. 1991, 34, 1521-1530.
5. Cools, M.; De Clercq, E. Biochem. Pharmacol. 1989, 38, 1061-1067.
6. a) Yaginuma, S.; Muto, N.; Tsujino, M.; Sudate, Y.; Hayashi, M.; Otani, M. J. Antibiot. 1981, 34, 359-366.
7. b) Hayashi, M.; Yaginuma, S.; Yoshioka, H.; Nakatsu, K. J. Antibiot. 1981, 34, 675-680.
8. Borchardt, R. T.; Keller, B. T.; Patel-Thombre, U. Neplanocin A. J. Biol. Chem. 1984, 259, 4353-4358.
9. De Clercq, E. Antimicrob. Agents Chemother. 1985, 28, 84-89.
10. a) Glazer, R. I.; Knode, M. C. J. Biol. Chem. 1984, 259, 12964-12969.
11. b) Inaba, M.; Nagashima, K.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1986, 46, 1063-1067.
12. c) Hoshi, A.; Yoshida, M.; Iigo, M.; Tokuzen, R.; Fukukawa, K.; Ueda, T. J. Phamacobio-Dyn. 1986, 9, 202-206.
13. a) Shuto, S.; Obara, T.; Toriya, M.; Hosoya, M.; Snoeck, R.; Andrei, G.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1992, 55, 324-331.
14. b) Shigeta, S.; Mori, S.; Baba, M.; Ito, M.; Honzumi, K.; Nakamura, K.; Oshitani, H.; Numazaki, Y.; Matsuda, A.; Obara, T.; Shuto, S.; De Clercq, E. Antimicrob. Agents Chemother. 1992, 36, 435-439.
15. c) Shuto, S.; Obara, T.; Itoh, H.; Kosugi, Y.; Saito, Y.; Toriya, M.; Yaginuma, S.; Shigeta, S.; Matsuda, A. Chem. Pharm. Bull. 1994, 42, 1688-1690.
16. d) Shuto, S.; Obara, T.; Kosugi, Y.; Saito, Y.; Toriya, M.; Yaginuma, S.; Shigeta, S.; Matsuda, A. BioMed. Chem. Lett. 1994, 4, 605-608.
17. For examples; a) Borcherding, D. R.; Narayanan, S; Hasobe, M.; McKee, J. G.; Keller, B. T.; Borchardt, R. T. J. Med. Chem. 1988, 31, 1729-1738. b) Tsend, C. K. H.; Marquez, V. E.; Fuller, R. W.; Goldstein, B. M.; Arnett, G.; Hollingshead, M.; Driscoll, J. S. J. Med. Chem. 1989, 32, 1442-1446. c) Hasobe, M.; Mckee, J. G.; Borcherding, D. R.; Borchardt, R. T. Antimicrob. Agents Chemother. 1987, 31, 1849-1851.
18. For examples; a) Borcherding, D. R.; Narayanan, S; Hasobe, M.; McKee, J. G.; Keller, B. T.; Borchardt, R. T. J. Med. Chem. 1988, 31, 1729-1738. b) Tsend, C. K. H.; Marquez, V. E.; Fuller, R. W.; Goldstein, B. M.; Arnett, G.; Hollingshead, M.; Driscoll, J. S. J. Med. Chem. 1989, 32, 1442-1446. c) Hasobe, M.; Mckee, J. G.; Borcherding, D. R.; Borchardt, R. T. Antimicrob. Agents Chemother. 1987, 31, 1849-1851.
19. For examples; a) Borcherding, D. R.; Narayanan, S; Hasobe, M.; McKee, J. G.; Keller, B. T.; Borchardt, R. T. J. Med. Chem. 1988, 31, 1729-1738. b) Tsend, C. K. H.; Marquez, V. E.; Fuller, R. W.; Goldstein, B. M.; Arnett, G.; Hollingshead, M.; Driscoll, J. S. J. Med. Chem. 1989, 32, 1442-1446. c) Hasobe, M.; Mckee, J. G.; Borcherding, D. R.; Borchardt, R. T. Antimicrob. Agents Chemother. 1987, 31, 1849-1851.
20. Paisley, S. D.; Wolfe, M. S.; Borchardt, R. T. J. Med. Chem. 1989, 32, 1415-1418.